Chinese Surgical Robots Surpass Da Vinci in Domestic Market Share, Expanding into Global Remote Surgery

MicroPort MedBot’s Toumai laparoscopic robot overtook Intuitive Surgical’s Da Vinci in China’s domestic market for the first time in Jan–May 2026.

The result signals a broader shift as Chinese surgical robot makers gain share from imported systems and strengthen local supply chains.

Other Chinese firms also expanded approved robots, AI-assisted procedures, and remote surgery capabilities for wider use.

The trend points to rising Chinese medtech competitiveness, with potential to improve access and help address workforce shortages.